Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||
| Net Income | -1,001 | -3,920 |
| Depreciation Amortization | 4 | 6 |
| Accounts receivable | 56 | N/A |
| Accounts payable and accrued liabilities | -102 | N/A |
| Other Working Capital | -5 | 9 |
| Other Operating Activity | 62 | 1,545 |
| Operating Cash Flow | $-986 | $-2,360 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 465 | N/A |
| PPE Investments | N/A | -20 |
| Purchase Of Investment | 2 | N/A |
| Sale Of Investment | 507 | N/A |
| Other Investing Activity | 0 | -1,020 |
| Investing Cash Flow | $974 | $-1,040 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 0 | 2,620 |
| Financing Cash Flow | $N/A | $2,620 |
| Beginning Cash Position | 55 | 830 |
| End Cash Position | 43 | 50 |
| Net Cash Flow | $-12 | $-780 |
| Free Cash Flow | ||
| Operating Cash Flow | -986 | -2,360 |
| Free Cash Flow | -986 | -2,360 |